Table 2

Clinical, ECG, and imaging features for differential diagnosis between AFD, cardiac amyloidosis, and sarcomeric hypertrophic cardiomyopathy (HCM)10

CardiomyopathyClinical evaluationECGEchocardiographic featuresSpeckle tracking echocardiographyCMR
AFDExtracardiac signs:
  • Neurological (acroparaesthesia, stroke-like events)

  • Renal (proteinuria, end-stage kidney failure)

  • Ocular (corneal dystrophy)

  • Cutaneous (angiokeratoma, hypohidrosis)

  • Gastrointestinal (abdominal pain, vomiting, diarrhoea)

ECG: short PR, conduction abnormalities
  • Severe concentric LVH

  • Preserved LVEF

  • Progressive increase in LV volumes

  • LV diastolic dysfunction

  • Reduced longitudinal strain in the basal posterior-lateral wall

  • Reduced free wall RV strain

  • LVH

  • LGE in the basal and mid-inferolateral

  • Low T1 values

  • Increased T2 values in LGE area

  • Normal ECV

Cardiac amyloidosisExtracardiac signs:
  • Neurological (carpal tunnel syndrome, peripheral neuropathy, autonomic neuropathy, spinal cord stenosis)

  • Ocular (cataract, vitreous opacity)

  • Normal or reduced QRS voltages

  • Q waves (pseudoinfarction pattern)

  • AF or conduction abnormalities

  • Concentric LVH, often RV hypertrophy

  • Preserved LVEF and progressive reduction in LV volumes

  • Biventricular and atrial septal hypertrophy

  • Biatrial enlargement

  • Pericardial effusion

  • Early LV diastolic dysfunction

  • Relative apical sparing pattern

  • Early LA strain reduction

  • Reduced RV strain pattern in severe disease

  • Reduced GCW and GWE by LV myocardial work

  • LVH

  • Subendocardial diffuse or transmural LGE

  • Increased ECV (>40%)

  • High T1 and low T2 values

HCMFamily history of sudden cardiac death/HCM
  • Meets voltage criteria for LVH

  • Biatrial enlargement

  • ST-T abnormalities

  • Asymmetrical hypertrophy with maximum wall thickness > 15 mm

  • Possible apical LVH

  • LVEF usually normal or mildly impaired

  • Possible presence of LVOTO and/or SAM with secondary MR (posteriorly directed jet)

Reduced longitudinal strain and GCW
  • LVH

  • No specific LGE pattern

  • T1 and ECV values slightly increased in hypertrophic areas

  • T2 values increased if oedema

CardiomyopathyClinical evaluationECGEchocardiographic featuresSpeckle tracking echocardiographyCMR
AFDExtracardiac signs:
  • Neurological (acroparaesthesia, stroke-like events)

  • Renal (proteinuria, end-stage kidney failure)

  • Ocular (corneal dystrophy)

  • Cutaneous (angiokeratoma, hypohidrosis)

  • Gastrointestinal (abdominal pain, vomiting, diarrhoea)

ECG: short PR, conduction abnormalities
  • Severe concentric LVH

  • Preserved LVEF

  • Progressive increase in LV volumes

  • LV diastolic dysfunction

  • Reduced longitudinal strain in the basal posterior-lateral wall

  • Reduced free wall RV strain

  • LVH

  • LGE in the basal and mid-inferolateral

  • Low T1 values

  • Increased T2 values in LGE area

  • Normal ECV

Cardiac amyloidosisExtracardiac signs:
  • Neurological (carpal tunnel syndrome, peripheral neuropathy, autonomic neuropathy, spinal cord stenosis)

  • Ocular (cataract, vitreous opacity)

  • Normal or reduced QRS voltages

  • Q waves (pseudoinfarction pattern)

  • AF or conduction abnormalities

  • Concentric LVH, often RV hypertrophy

  • Preserved LVEF and progressive reduction in LV volumes

  • Biventricular and atrial septal hypertrophy

  • Biatrial enlargement

  • Pericardial effusion

  • Early LV diastolic dysfunction

  • Relative apical sparing pattern

  • Early LA strain reduction

  • Reduced RV strain pattern in severe disease

  • Reduced GCW and GWE by LV myocardial work

  • LVH

  • Subendocardial diffuse or transmural LGE

  • Increased ECV (>40%)

  • High T1 and low T2 values

HCMFamily history of sudden cardiac death/HCM
  • Meets voltage criteria for LVH

  • Biatrial enlargement

  • ST-T abnormalities

  • Asymmetrical hypertrophy with maximum wall thickness > 15 mm

  • Possible apical LVH

  • LVEF usually normal or mildly impaired

  • Possible presence of LVOTO and/or SAM with secondary MR (posteriorly directed jet)

Reduced longitudinal strain and GCW
  • LVH

  • No specific LGE pattern

  • T1 and ECV values slightly increased in hypertrophic areas

  • T2 values increased if oedema

AF, atrial fibrillation; ECV, extracellular volume; GCW, global constructive work; GWE, global work efficiency; HCM, hypertrophic cardiomyopathy; LGE, late gadolinium enhancement; LV, left ventricular; LVEF, left ventricular ejection fraction; LVH, left ventricular hypertrophy; LVOTO, left ventricular outflow tract obstruction; MR, mitral regurgitation; RV, right ventricle; SAM, systolic anterior motion.

Table 2

Clinical, ECG, and imaging features for differential diagnosis between AFD, cardiac amyloidosis, and sarcomeric hypertrophic cardiomyopathy (HCM)10

CardiomyopathyClinical evaluationECGEchocardiographic featuresSpeckle tracking echocardiographyCMR
AFDExtracardiac signs:
  • Neurological (acroparaesthesia, stroke-like events)

  • Renal (proteinuria, end-stage kidney failure)

  • Ocular (corneal dystrophy)

  • Cutaneous (angiokeratoma, hypohidrosis)

  • Gastrointestinal (abdominal pain, vomiting, diarrhoea)

ECG: short PR, conduction abnormalities
  • Severe concentric LVH

  • Preserved LVEF

  • Progressive increase in LV volumes

  • LV diastolic dysfunction

  • Reduced longitudinal strain in the basal posterior-lateral wall

  • Reduced free wall RV strain

  • LVH

  • LGE in the basal and mid-inferolateral

  • Low T1 values

  • Increased T2 values in LGE area

  • Normal ECV

Cardiac amyloidosisExtracardiac signs:
  • Neurological (carpal tunnel syndrome, peripheral neuropathy, autonomic neuropathy, spinal cord stenosis)

  • Ocular (cataract, vitreous opacity)

  • Normal or reduced QRS voltages

  • Q waves (pseudoinfarction pattern)

  • AF or conduction abnormalities

  • Concentric LVH, often RV hypertrophy

  • Preserved LVEF and progressive reduction in LV volumes

  • Biventricular and atrial septal hypertrophy

  • Biatrial enlargement

  • Pericardial effusion

  • Early LV diastolic dysfunction

  • Relative apical sparing pattern

  • Early LA strain reduction

  • Reduced RV strain pattern in severe disease

  • Reduced GCW and GWE by LV myocardial work

  • LVH

  • Subendocardial diffuse or transmural LGE

  • Increased ECV (>40%)

  • High T1 and low T2 values

HCMFamily history of sudden cardiac death/HCM
  • Meets voltage criteria for LVH

  • Biatrial enlargement

  • ST-T abnormalities

  • Asymmetrical hypertrophy with maximum wall thickness > 15 mm

  • Possible apical LVH

  • LVEF usually normal or mildly impaired

  • Possible presence of LVOTO and/or SAM with secondary MR (posteriorly directed jet)

Reduced longitudinal strain and GCW
  • LVH

  • No specific LGE pattern

  • T1 and ECV values slightly increased in hypertrophic areas

  • T2 values increased if oedema

CardiomyopathyClinical evaluationECGEchocardiographic featuresSpeckle tracking echocardiographyCMR
AFDExtracardiac signs:
  • Neurological (acroparaesthesia, stroke-like events)

  • Renal (proteinuria, end-stage kidney failure)

  • Ocular (corneal dystrophy)

  • Cutaneous (angiokeratoma, hypohidrosis)

  • Gastrointestinal (abdominal pain, vomiting, diarrhoea)

ECG: short PR, conduction abnormalities
  • Severe concentric LVH

  • Preserved LVEF

  • Progressive increase in LV volumes

  • LV diastolic dysfunction

  • Reduced longitudinal strain in the basal posterior-lateral wall

  • Reduced free wall RV strain

  • LVH

  • LGE in the basal and mid-inferolateral

  • Low T1 values

  • Increased T2 values in LGE area

  • Normal ECV

Cardiac amyloidosisExtracardiac signs:
  • Neurological (carpal tunnel syndrome, peripheral neuropathy, autonomic neuropathy, spinal cord stenosis)

  • Ocular (cataract, vitreous opacity)

  • Normal or reduced QRS voltages

  • Q waves (pseudoinfarction pattern)

  • AF or conduction abnormalities

  • Concentric LVH, often RV hypertrophy

  • Preserved LVEF and progressive reduction in LV volumes

  • Biventricular and atrial septal hypertrophy

  • Biatrial enlargement

  • Pericardial effusion

  • Early LV diastolic dysfunction

  • Relative apical sparing pattern

  • Early LA strain reduction

  • Reduced RV strain pattern in severe disease

  • Reduced GCW and GWE by LV myocardial work

  • LVH

  • Subendocardial diffuse or transmural LGE

  • Increased ECV (>40%)

  • High T1 and low T2 values

HCMFamily history of sudden cardiac death/HCM
  • Meets voltage criteria for LVH

  • Biatrial enlargement

  • ST-T abnormalities

  • Asymmetrical hypertrophy with maximum wall thickness > 15 mm

  • Possible apical LVH

  • LVEF usually normal or mildly impaired

  • Possible presence of LVOTO and/or SAM with secondary MR (posteriorly directed jet)

Reduced longitudinal strain and GCW
  • LVH

  • No specific LGE pattern

  • T1 and ECV values slightly increased in hypertrophic areas

  • T2 values increased if oedema

AF, atrial fibrillation; ECV, extracellular volume; GCW, global constructive work; GWE, global work efficiency; HCM, hypertrophic cardiomyopathy; LGE, late gadolinium enhancement; LV, left ventricular; LVEF, left ventricular ejection fraction; LVH, left ventricular hypertrophy; LVOTO, left ventricular outflow tract obstruction; MR, mitral regurgitation; RV, right ventricle; SAM, systolic anterior motion.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close